Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stem Cell Congress 2020

About Us

We cordially welcome all the global participants to the 14th International Conference of Stem Cell and Regenerative Medicine which will be held during September 24-25, 2020 carrying the theme as 'Stem Cells: Innovations and Applications’ in Paris, France this social gathering is an opportunity to get connected with the top researchers of the world in the fields of Stem Cell Researches, Genetics, Biotechnology, Pharmaceuticals, etc.

Stem cell 2020 warmly welcomes the researchers and developers, professionals who are studying or analyzing in the fields of Stem Cell, Genetics, Regenerative Medicine, Cell Biology, etc., and other associated organizations to participate in the event and grasp knowledge about the recent researches regarding stem cell and regenerative medicine and their analysis. This conference will consist of the keynote talks, session talks, oral presentations, poster presentations, B2B networking etc. The aim of this global conference is to promote the recent advances in Stem Cell Therapy Research with its applications as well as the cell and gene therapy which stands as the new therapeutic approaches. The conference will also support and motivate the young researches in the fields of Stem Cells and Genetics Research to meet the new advancements.

We sincerely hope that Stem cell 2020 would serve as an international platform, creating new opportunities in the Stem Cell and Regenerative Medicine Research.

 

Why to attend the Conference:

Presenting your ideas and work gives you new perspective about work as people may ask questions that make you think about your project differently. Gaining expert knowledge, exchanging views and information and allowing them to discuss tomorrow’s challenges in Stem Cells. This event emphasizes at bringing the advancements in the fields of regenerative Medicine, Stem cells and related fields.

Who should attend?

We welcome all Individuals representing academia, public health researchers and practitioners, Stem cell researchers, Biology-practitioners, Immunologists & Microbiologist, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, students, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors  related to Regenerative Medicine and Stem Cell research and business. We also invite industry scientists who are interested in targets for novel therapies. This is an excellent forum for informal networking and meeting potential collaborators.

 

Scientific Sessions

Session 1: Stem Cell Developers and Investigators

A cell having ability to develop into specialized cell types in body which replace the damaged or lost cells or tissues. Generally, natural stem cells are classified into embryonic stem cells and adult stem cells and the type of stem cells are reprogrammed in the laboratory are Induced Pluripotent Stem Cell. Basing on the efficiency or potency stem cells are classified into Totipotent, Multipotent, Pluripotent, Oligopotent, Unipotent. Stem cell therapy or regenerative medicine is the treatment method which develops methods to regrow repair or replace damaged or diseased cells, organs or tissues.

Session 2: Tissue Engineering and 3D Cell Culture

The procedure in which the cells are grown in an artificial environment separate from the body is called tissue engineering. It is an improvisation of growing cells than methods of 2D cell culture. The cells growing in 3D artificial environment are more relevant and effective than the cells growing in the 2D surface. The basic method of the 3D cell culture leads to the use of scaffolds which are the engineered materials which leads to cellular interaction in new tissues to be functional.

Session 3: Gene and Cell Therapy

Gene therapy is a way to treat the genetic disorders. The variation in gene therapy is focused on somatic gene therapy and germ line gene therapy relating with viral and non-viral vectors. T-cells are the type of lymphocyte cells which are developed in the laboratory to attack the cancer cells. T-cell therapy is nothing but an immune therapy to treat certain kinds of cancer. The nano therapy is a new trend in the field of medicine which uses nanoparticles to delivery drugs to the targeted body part.

Session 4: Ageing Theories in Stem Cell

Ageing is the complex process of deterioration of body functions through involvement of body cells and organs. Basically the ageing theory can be divided into two types – hematopoietic stem cell ageing and hair follicle stem cell ageing. Besides these two theories, the other theories of ageing are evolutionary theory, cellular theory, system theory and molecular theory. With ageing the bone marrow cellularity decreases.

Session 5: Epigenetics and Stem Biology

The study of heritable phenotypic change which does not involve any change or alteration in DNA sequencing is known as Epigenetics.  These changes make modification in certain gene activities like histone modification, adding a methyl group to a part of a DNA molecule. The DNA alterations are not termed as genetic, rather they are called epigenetic.

Session 6: Stem Cell Apoptosis and Signal Transduction

Apoptosis is the cell death which leads to a programming sequence of the elimination of old, unnecessary, unhealthy cells. This process is also known as cell suicide. When a cell commits suicide then the caspases become active. The signal transduction is a process in which the signals are transferred in an organism across the cells. In this process the proteins are termed as the receptors. The protein receptor gets signal through a primary messenger and then, undergoes conformational changes which changes its shape and interacts with molecules surrounding it.

Session 7: Genome Editing Technology

The technology which makes specific changes in the DNA of a cell. Genome editing depends on the double strand DNA break which has two major pathway mechanisms – non-homologous end joining (NHEJ) and homologous directed repair (HDR).  The genome editing technology heads with the processes like CRISPR, TALEN, ZNF and MAGE.

Session 8: Stem Cell Transplants for Cancer Treatment

In a typical stem cell transplant for cancer terribly high doses of chemo are used, sometimes in conjunction with radiotherapy to undertake to kill all the cancer cells. This treatment additionally kills the stem cells within the bone marrow. Soon after treatment, stem cells are given to exchange those that were destroyed. These stem cells are given into a vein, very similar to a blood transfusion. Over time they settle within the bone marrow and start to grow and create healthy blood cells. This process is called engraftment.

Session 9: Tissue-Engineered Disease Models

Tissue remodeling is a technique of tissue engineering which involves restoration or reprogramming of tissues. It results in the maintenance and growth of the tissues. The cells which undergo pathological processes in observing the diseases of humans or animals is termed as organ models. Tissue engineering makes the improved format of modeling the phenotypes and screening the therapeutic solutions to the particular disease.

Session 10: Clinical Tissues Analysis

Clinical tissue analysis correlates with histopathology which involves the examination of tissues in order to manifest the diseases. The method requires the hematoxylin and eosin (H and E stain) to identify tissues. Tissue analysis includes the method called Automated Tissue Image Analysis which is a computer controlled method in clinical or medical science, pharmaceuticals, etc.

Session 11: Biomaterials and Biomedical Applications

The material or device or equipment required for treatment or for diagnosis is termed as a biomaterial. The biomaterials have broad application in the clinical or medical science. Hence, to study on biomaterials it is termed as biomaterial science and biomaterial engineering which is profoundly related with biomedical as well as research sector. The application of principles of biology and tools of engineering to create usable, tangible, economically viable products is termed as biomedical application of biomaterials.

Session 12: 3D Bio-Printing and Organ Printing

The 3D technique is a tissue imitating technology which combines cells and their growth factors along with biomaterials. It is used in printing tissues, cells, organs, etc. it requires bio-ink to print the tissues, cells and organs structurally layer-layer. The methods of 3D bio printing include Pre bio printing, Bio printing and Post bio printing. Organ printing is categorized as Drop-based Bio printing and Extrusion bio printing.

Session 13: Bioinformatics and Computational Biology

Bioinformatics and computational science are relevant orders enabling computational techniques to break down instinctive information and create calculations and scientific strategies by learning from different orders like software engineering, material science & measurements. This field is picking up significance in different research fields like Neural Networks. Subfields identified with this theme are computational pharmacology, computational immunology, computational disease science, computational neuroscience, and so forth this field is picking up significance in different research fields like Neural Networks. Subfields identified with this theme are computational immunology, computational pharmacology, computational neuroscience, computational disease science and so forth.

Market Analysis

Market Growth of Stem Cell & Regenerative Medicine Research:

Global Market of Regenerative Medicines anticipated achieving USD 30,237 million by 2022.Current Research says that, Regenerative Medicine has opened several insights in the field of Health and Medicine and approaches to treat and cure complex degenerative, Neurological and genetic, acquired as well as hereditary disorder and to restore the function of tissues and cells in the damaged and missing organs by other therapies. North America takes the lead in global market in 2015 and expected to remain ascendant during 2015-2022. Stem Cell Therapies are also used to treat cancer and different immunodeficiency and Auto immune syndromes. And now Stem Cells are also stands as a new weapon against Neurodegenerative Diseases, cardiovascular Diseases. Eyesight syndromes, wound healing, spinal cord injury, etc.

The worldwide Stem cell & regenerative medicines market is functional with several parameters like product type, application, sources, geography and users.  In focused to the product type stem cells market is divided into human embryonic stem cells, adult stem cells, IPsec’s, etc. Whereas, regenerative medicines applied the potential of these stem cells to regenerate, repair & replace tissues or the organ which are affected due to injury, natural aging process, and some diseases.

These novel approaches are able to restore the performance of cells & tissues and applied in broad range of fields starting form Tissue Engineering to cosmetic surgery therefore, now it seeks the central attraction of researchers to focuses on the new technologies like Utilization of Nano-materials in immunomodulation, drug delivery to make the growth in regenerative medicines market and blend it with stem cell culture to open new insights, possibilities which can bring evolution in the field of medicine.

Market Study of Stem Cells & Regenerative Medicine:

Europe: The regenerative medicine & stem cells market is expected to reach USD 13.578 billion by 2022 from USD 5.06 billion in 2016 at a CAGR of 21.80% during the period 2016-2022.

Middle East: The regenerative medicines market is expected $ 40.55 billion revenue in 2022 from $ 17.03 billion revenue in 2016.

USA: The regenerative medicine & stem cell market is assuming to reach $38.70 billion by the year 2022 from $ 13.33 billion in 2016 at a CAGR of 23.56%.

To Collaborate Scientific Professionals around the World

Conference Date September 24-25, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Molecular Biomarkers and Diagnosis Journal of Molecular and Genetic medicine Journal of Phylogenetics and Evolutionary biology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by